Ignite Creation Date:
2025-12-24 @ 11:32 PM
Ignite Modification Date:
2025-12-25 @ 9:20 PM
Study NCT ID:
NCT04802356
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-17
First Post:
2021-03-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Belantamab Mafodotin in Newly Diagnosed Transplant Eligible Multiple Myeloma Patients
Sponsor:
PETHEMA Foundation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-07
Start Date Type:
ACTUAL
Primary Completion Date:
2025-03-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-12
Completion Date Type:
ESTIMATED
First Submit Date:
2021-03-12
First Submit QC Date:
None
Study First Post Date:
2021-03-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-09
Last Update Post Date:
2025-12-17
Last Update Post Date Type:
ESTIMATED